Linlin Song

2.0k total citations
94 papers, 1.5k citations indexed

About

Linlin Song is a scholar working on Biomedical Engineering, Molecular Biology and Materials Chemistry. According to data from OpenAlex, Linlin Song has authored 94 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Biomedical Engineering, 19 papers in Molecular Biology and 17 papers in Materials Chemistry. Recurrent topics in Linlin Song's work include Advanced Sensor and Energy Harvesting Materials (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Advanced Photocatalysis Techniques (7 papers). Linlin Song is often cited by papers focused on Advanced Sensor and Energy Harvesting Materials (9 papers), Nanoplatforms for cancer theranostics (8 papers) and Advanced Photocatalysis Techniques (7 papers). Linlin Song collaborates with scholars based in China, Macao and United States. Linlin Song's co-authors include Lisha Zhang, Zhigang Chen, Jianshe Liu, Junqing Hu, Qian Wang, Huanli Wang, Meifang Zhu, Dongyuan Zhao, Guosheng Song and Hongzhi Wang and has published in prestigious journals such as Advanced Materials, The Journal of Chemical Physics and Applied Physics Letters.

In The Last Decade

Linlin Song

82 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Linlin Song China 20 556 510 283 255 250 94 1.5k
Shubham Roy India 23 765 1.4× 543 1.1× 255 0.9× 152 0.6× 246 1.0× 100 1.5k
Jianhua Ran China 29 617 1.1× 434 0.9× 534 1.9× 301 1.2× 271 1.1× 99 2.2k
Yuting Cai China 23 306 0.6× 517 1.0× 204 0.7× 240 0.9× 473 1.9× 82 1.5k
Meng Luo China 23 438 0.8× 357 0.7× 498 1.8× 207 0.8× 517 2.1× 65 2.2k
Na Yang China 23 716 1.3× 806 1.6× 351 1.2× 243 1.0× 245 1.0× 70 1.8k
Shan Han China 26 399 0.7× 237 0.5× 516 1.8× 155 0.6× 175 0.7× 81 2.0k
Min Guo China 18 365 0.7× 527 1.0× 255 0.9× 130 0.5× 361 1.4× 54 1.3k
Kehua Zhang China 25 293 0.5× 541 1.1× 339 1.2× 249 1.0× 246 1.0× 86 1.7k
Olli Pitkänen Finland 23 286 0.5× 371 0.7× 154 0.5× 171 0.7× 429 1.7× 64 1.4k
Keke Zhao China 16 514 0.9× 770 1.5× 210 0.7× 116 0.5× 358 1.4× 57 1.7k

Countries citing papers authored by Linlin Song

Since Specialization
Citations

This map shows the geographic impact of Linlin Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Linlin Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Linlin Song more than expected).

Fields of papers citing papers by Linlin Song

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Linlin Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Linlin Song. The network helps show where Linlin Song may publish in the future.

Co-authorship network of co-authors of Linlin Song

This figure shows the co-authorship network connecting the top 25 collaborators of Linlin Song. A scholar is included among the top collaborators of Linlin Song based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Linlin Song. Linlin Song is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Meixu, Linlin Song, Ruhong Zhou, et al.. (2025). Promotion of triple negative breast cancer immunotherapy by combining bioactive radicals with immune checkpoint blockade. Acta Biomaterialia. 194. 305–322. 5 indexed citations
2.
Song, Linlin, Yong Tang, Yuan Qing Qu, et al.. (2025). Exosomal delivery of rapamycin modulates blood-brain barrier penetration and VEGF axis in glioblastoma. Journal of Controlled Release. 381. 113605–113605. 10 indexed citations
3.
Lin, Lin, Rong Li, Ying Zhang, et al.. (2025). Patient pathway analysis of rifampicin-resistant TB diagnostic and treatment delays. PubMed. 2(2). 90–95. 1 indexed citations
4.
Chen, Meixu, Linlin Song, Zhihui Liu, et al.. (2025). A cisplatin prodrug-based self-assembling ozone delivery nanosystem sensitizes radiotherapy in triple-negative breast cancer. Acta Pharmaceutica Sinica B. 15(5). 2703–2722.
5.
Wu, Jiao, Xiaoyan Du, Shuangling Zhang, et al.. (2025). Chemical profiling, discriminant analysis, antioxidants, and anti-inflammatory activities of Lonicerae Japonicae Flos tea varieties. Future Foods. 11. 100642–100642.
6.
Song, Linlin, et al.. (2025). Extensive gene mining and facile engineering of a novel carbonyl reductase for asymmetric synthesis of anti-aging (S)-Pro-Xylane from d-xylose. International Journal of Biological Macromolecules. 305(Pt 2). 140976–140976. 1 indexed citations
7.
Song, Linlin, Xin Wang, Ruhong Zhou, et al.. (2025). Blockade of metastasis by targeting circulating tumor cells with platelet encapsuled oncolytic adenovirus. Biomaterials. 326. 123674–123674.
8.
Song, Linlin, et al.. (2024). Research on real-time monitoring and early warning of Tangshan road surface subsidence based on InSAR. Advances in Space Research. 75(6). 4408–4430. 2 indexed citations
9.
Liu, Xuedong, Linlin Song, Wenwen Liu, et al.. (2024). Solamargine inhibits gastric cancer progression via inactivation of STAT3/PD‑L1 signaling. Molecular Medicine Reports. 31(2).
10.
Ye, Panpan, Yang Yang, Qian Li, et al.. (2024). Drug-drug interactions of simnotrelvir/ritonavir: an open-label, fixed-sequence, two-period clinical trial. Clinical Microbiology and Infection. 31(1). 101–107.
11.
12.
Song, Linlin, Haiyan Zhou, Panpan Ye, et al.. (2023). A first‐in‐human phase I study of SHR‐1906, a humanized monoclonal antibody against connective tissue growth factor, in healthy participants. Clinical and Translational Science. 16(12). 2604–2613. 4 indexed citations
13.
Song, Linlin, Jinshun Xu, Zhihui Liu, et al.. (2022). Improvement of TNBC immune checkpoint blockade with a microwave-controlled ozone release nanosystem. Journal of Controlled Release. 351. 954–969. 11 indexed citations
14.
Wang, Xueyan, Jing Yu, Xiaowei Liu, et al.. (2022). PSMG2-controlled proteasome-autophagy balance mediates the tolerance for MEK-targeted therapy in triple-negative breast cancer. Cell Reports Medicine. 3(9). 100741–100741. 20 indexed citations
15.
Zhang, Wei, Yue‐E Wu, Xiaoyan Yang, et al.. (2020). Oral drugs used to treat persistent pulmonary hypertension of the newborn. Expert Review of Clinical Pharmacology. 13(12). 1295–1308. 6 indexed citations
16.
Song, Linlin, et al.. (2020). Injury to the human retrosplenial cortex: Two cases and a review of the literature. 20(3). 2 indexed citations
17.
Liu, Shaohua, et al.. (2020). Repeated successful vaginal delivery in a pregnant woman with unrepaired ectopia vesicae and split pelvis: a case study. BMC Pregnancy and Childbirth. 20(1). 290–290.
18.
Song, Linlin, et al.. (2018). Comparison of two different models of sepsis induced by cecal ligation and puncture in rats. Journal of Surgical Research. 229. 277–282. 12 indexed citations
20.
Chen, Zhigang, Qian Wang, Huanli Wang, et al.. (2013). Ultrathin PEGylated W18O49 Nanowires as a New 980 nm‐Laser‐Driven Photothermal Agent for Efficient Ablation of Cancer Cells In Vivo. Advanced Materials. 25(14). 2095–2100. 361 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026